Trial Profile
Pharmacokinetic/pharmacodynamic study of monteplase ('Cleactor') in acute pulmonary embolism
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Monteplase (Primary)
- Indications Pulmonary embolism
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Eisai Inc
- 07 Jul 2008 The actual completion date for this trial is now April 2008 as reported by ClinicalTrials.gov
- 07 Jul 2008 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 06 Apr 2007 New trial record.